All Stories

  1. Inhibition of miR-181c-5p Rescues Diabetes-Impaired Angiogenesis in Ischemia and Wound Healing
  2. Reconstituted High-Density Lipoproteins Rescue Diabetes-Impaired Endothelial Cell Metabolic Reprograming and Angiogenic Responses to Hypoxia
  3. Reconstituted high-density lipoproteins rescue diabetes-impaired endothelial cell metabolic reprograming and angiogenic responses to hypoxia
  4. Exercise Reduces Glucose Intolerance, Cardiac Inflammation and Adipose Tissue Dysfunction in Psammomys obesus Exposed to Short Photoperiod and High Energy Diet
  5. Female Psammomys obesus Are Protected from Circadian Disruption-Induced Glucose Intolerance, Cardiac Fibrosis and Adipocyte Dysfunction
  6. TRIM2 Selectively Regulates Inflammation-Driven Pathological Angiogenesis without Affecting Physiological Hypoxia-Mediated Angiogenesis
  7. TRIM2 Selectively Regulates Inflammation-Driven Pathological Angiogenesis without Affecting Physiological Hypoxia-Mediated Angiogenesis
  8. Multifunctional biomimetic porphyrin-lipid nanoparticles – novel nanoscale theranostics for atherosclerotic cardiovascular disease
  9. A roadmap of strategies to support cardiovascular researchers: from policy to practice
  10. Pro-Calcific Environment Impairs Ischaemia-Driven Angiogenesis
  11. Lifestyle Modifies the Diabetes-Related Metabolic Risk, Conditional on Individual Genetic Differences
  12. Strategies to support early- and mid-career cardiovascular researchers to thrive
  13. Eukaryotic elongation factor 2 kinase regulates foam cell formation via translation of CD36
  14. Discovery of embryonically derived bipotent endothelial-macrophage progenitor cells in postnatal aorta
  15. The Role of miR-181c in Mechanisms of Diabetes-Impaired Angiogenesis: An Emerging Therapeutic Target for Diabetic Vascular Complications
  16. Circadian disruption by short light exposure and a high energy diet impairs glucose tolerance and increases cardiac fibrosis in Psammomys obesus
  17. Omega-3 fatty acids ameliorate vascular inflammation: A rationale for their atheroprotective effects
  18. Elevated HDL-bound miR-181c-5p level is associated with diabetic vascular complications in Australian Aboriginal people
  19. Lifestyle modifies the diabetes-related metabolic risk, conditional on individual genetic differences
  20. Lack of Strategic Funding and Long-Term Job Security Threaten to Have Profound Effects on Cardiovascular Researcher Retention in Australia
  21. The Role of High-Density Lipoproteins in Endothelial Cell Metabolism and Diabetes-Impaired Angiogenesis
  22. The multiple roles of chemokines in the mechanisms of stent biocompatibility
  23. High-Energy Diet and Shorter Light Exposure Drives Markers of Adipocyte Dysfunction in Visceral and Subcutaneous Adipose Depots of Psammomys obesus
  24. MicroRNAs as Therapeutic Targets and Clinical Biomarkers in Atherosclerosis
  25. Inflammation as a Therapeutic Target in Atherosclerosis
  26. A Role for Chlorinated Nucleosides in the Perturbation of Macrophage Function and Promotion of Inflammation
  27. Fenofibrate Rescues Diabetes-Related Impairment of Ischemia-Mediated Angiogenesis by PPARα-Independent Modulation of Thioredoxin-Interacting Protein
  28. The Role of Chemokines in Wound Healing
  29. The regulation of miRNAs by reconstituted high-density lipoproteins in diabetes-impaired angiogenesis
  30. Exploring the Roles of CREBRF and TRIM2 in the Regulation of Angiogenesis by High-Density Lipoproteins
  31. The Role of High-Density Lipoproteins in Diabetes and Its Vascular Complications
  32. VEGFR2 is activated by high-density lipoproteins and plays a key role in the proangiogenic action of HDL in ischemia
  33. Apolipoprotein A-I Reduces In-Stent Restenosis and Platelet Activation and Alters Neointimal Cellular Phenotype
  34. Strikingly Different Atheroprotective Effects of Apolipoprotein A-I in Early- Versus Late-Stage Atherosclerosis
  35. Plasma activated coating immobilizes apolipoprotein A-I to stainless steel surfaces in its bioactive form and enhances biocompatibility
  36. Estrogen Receptor Control of Atherosclerotic Calcification and Smooth Muscle Cell Osteogenic Differentiation
  37. Chemokine binding protein ‘M3’ limits atherosclerosis in apolipoprotein E-/- mice
  38. Broad-Spectrum Inhibition of the CC-Chemokine Class Improves Wound Healing and Wound Angiogenesis
  39. CC-chemokine class inhibition attenuates pathological angiogenesis while preserving physiological angiogenesis
  40. Androgen Receptor-Mediated Genomic Androgen Action Augments Ischemia-Induced Neovascularization
  41. The Role of CC-Chemokines in the Regulation of Angiogenesis
  42. Reconstituted high-density lipoproteins promote wound repair and blood flow recovery in response to ischemia in aged mice
  43. High-Density Lipoproteins Rescue Diabetes-Impaired Angiogenesis via Scavenger Receptor Class B Type I
  44. The Vascular Endothelial Growth Factor Inhibitors Ranibizumab and Aflibercept Markedly Increase Expression of Atherosclerosis-Associated Inflammatory Mediators on Vascular Endothelial Cells
  45. The role of high-density lipoproteins in the regulation of angiogenesis
  46. High density lipoproteins improve insulin sensitivity in high-fat diet-fed mice by suppressing hepatic inflammation
  47. Multifunctional regulation of angiogenesis by high-density lipoproteins
  48. High-density lipoproteins augment hypoxia-induced angiogenesis via regulation of post-translational modulation of hypoxia-inducible factor 1 
  49. Connective tissue growth factor/CCN-2 is upregulated in epididymal and subcutaneous fat depots in a dietary-induced obesity model
  50. Murine Model of Wound Healing
  51. High density Lipoproteins Augment Hypoxia-induced Angiogenesis In Vitro Via the HIF-1a/VEGF Pathway
  52. The apolipoprotein A-I mimetic peptide, ETC-642, reduces chronic vascular inflammation in the rabbit
  53. Effect of Exposure of Human Monocyte-Derived Macrophages to High, versus Normal, Glucose on Subsequent Lipid Accumulation from Glycated and Acetylated Low-Density Lipoproteins
  54. The myeloperoxidase-derived oxidant HOSCN inhibits protein tyrosine phosphatases and modulates cell signalling via the mitogen-activated protein kinase (MAPK) pathway in macrophages
  55. Experiences of Chinese Immigrants and Anglo-Australians Ageing in Australia
  56. The Myeloperoxidase-derived Oxidant HOSCN Inhibits Protein Tyrosine Phosphatases and Modulates Cell Signalling via the Mitogen-activated Protein Kinase (MAPK) Pathway in Macrophages
  57. Role of 3β-Hydroxysteroid-Δ24 Reductase in Mediating Antiinflammatory Effects of High-Density Lipoproteins in Endothelial Cells
  58. Connective tissue growth factor inhibits adipocyte differentiation
  59. Correlations of HBV Genotypes, Mutations Affecting HBeAg Expression and HBeAg/ anti-HBe Status in HBV Carriers